AKER BIOMARINE ASA (AKBM.OL) Stock Price, Forecast & Analysis
Europe - Euronext Oslo - OSL:AKBM - NO0010886625 - Common Stock
AKBM.OL Key Statistics, Chart & Performance
The current stock price of AKBM.OL is 80 NOK. In the past month the price decreased by -8.99%. In the past year, price increased by 40.11%.
AKBM.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BSN.DE | DANONE | 20.98 | 53.48B | ||
| BN.PA | DANONE | 20.98 | 53.46B | ||
| JDE.DE | JDE PEET'S NV | 25.39 | 15.37B | ||
| JDEP.AS | JDE PEET'S NV | 25.39 | 15.37B | ||
| KRZ.I | KERRY GROUP PLC-A | 16.2 | 12.68B | ||
| LOTB.BR | LOTUS BAKERIES | 39.21 | 6.32B | ||
| GL9.I | GLANBIA PLC | 12.29 | 3.51B | ||
| LOUP.PA | L.D.C. SA | 12.78 | 3.17B | ||
| SZU.DE | SUEDZUCKER AG | N/A | 1.95B | ||
| SAVE.PA | SAVENCIA SA | 8.58 | 813.74M | ||
| NWL.MI | NEWPRINCES SPA | 2.21 | 742.59M | ||
| FLOB.BR | FLORIDIENNE | 69.78 | 575.00M |
Related stock screener links
About AKBM.OL
Company Profile
Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus and currently employs 249 full-time employees. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
Company Info
AKER BIOMARINE ASA
Oksenoyveien 10, P.O. Box 496
Lysaker AKERSHUS NO
Employees: 249
Phone: 4724130000
AKER BIOMARINE ASA / AKBM.OL FAQ
Can you describe the business of AKER BIOMARINE ASA?
Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus and currently employs 249 full-time employees. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
What is the current price of AKBM stock?
The current stock price of AKBM.OL is 80 NOK. The price decreased by -2.44% in the last trading session.
Does AKBM stock pay dividends?
AKBM.OL does not pay a dividend.
What is the ChartMill rating of AKER BIOMARINE ASA stock?
AKBM.OL has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the PE ratio for AKBM stock?
The PE ratio for AKER BIOMARINE ASA (AKBM.OL) is 3.95. This is based on the reported non-GAAP earnings per share of 20.26 and the current share price of 80 NOK.
Can you provide the growth outlook for AKER BIOMARINE ASA?
The Revenue of AKER BIOMARINE ASA (AKBM.OL) is expected to decline by -14.23% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
When does AKER BIOMARINE ASA (AKBM.OL) report earnings?
AKER BIOMARINE ASA (AKBM.OL) will report earnings on 2026-02-10, after the market close.
AKBM.OL Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to AKBM.OL. When comparing the yearly performance of all stocks, AKBM.OL is one of the better performing stocks in the market, outperforming 76.87% of all stocks.
AKBM.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AKBM.OL. While AKBM.OL is still in line with the averages on profitability rating, there are concerns on its financial health.
AKBM.OL Financial Highlights
Over the last trailing twelve months AKBM.OL reported a non-GAAP Earnings per Share(EPS) of 20.26. The EPS increased by 15747.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 67.04% | ||
| ROA | 44.73% | ||
| ROE | 115.79% | ||
| Debt/Equity | 1.06 |
AKBM.OL Forecast & Estimates
9 analysts have analysed AKBM.OL and the average price target is 86.7 NOK. This implies a price increase of 8.38% is expected in the next year compared to the current price of 80.
For the next year, analysts expect an EPS growth of 60% and a revenue growth -14.23% for AKBM.OL